Skip to main content

18-07-2018 | Medications | Article

Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: Open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis

Genovese MC et al. Rheumatology (Oxford) 2018: key173. doi: 10.1093/rheumatology/key173

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

Image Credits